| Bethany Bixler Quinn, PA | |
|
3820 Medical Park Dr, Austell, GA 30106-1110 | |
| (770) 948-6041 | |
| (770) 819-2987 |
| Full Name | Bethany Bixler Quinn |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 17 Years |
| Location | 3820 Medical Park Dr, Austell, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114105335 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 005125 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Piedmont Hospital | Atlanta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Piedmont Providers Llc | 9830082825 | 371 |
News Archive
Cancer scientists led by Dr. John Dick at the Princess Margaret Cancer Centre have found a way to follow single tumour cells and observe their growth over time. By using special immune-deficient mice to propagate human colorectal cancer, they found that genetic mutations, regarded by many as the chief suspect driving cancer growth, are only one piece of the puzzle. The team discovered that biological factors and cell behaviour - not only genes - drive tumour growth, contributing to therapy failure and relapse.
United Auto Workers will sell its 55% stake in the reorganized Chrysler as soon as possible to fund a trust that will cover retirees' health care costs, UAW President Ron Gettelfinger said Monday, the AP/Houston Chronicle reports.
Secondhand tobacco smoke and smoke from cooking oil and wood smoke affected cardiovascular function of men and women who were exposed to small doses of the smoke for as little as 10 minutes, according to a study from the University of Kentucky.
The U.S. Food and Drug Administration today approved Xalkori (crizotinib) to treat people with advanced (metastatic) non-small cell lung cancer (NSCLC) whose tumors have an ROS-1 gene alteration. Xalkori is the first and only FDA approved treatment for patients with ROS-1 positive NSCLC.
Results from a multinational phase II study presented today at the International Liver CongressTM 2010 have shown that treatment with the caspase inhibitor GS-9450 can reduce markers of liver damage in patients with non-alcoholic steatohepatitis (NASH - the most serious form of non-alcoholic liver disease) as demonstrated by reduced levels of alanine and aspartate aminotransferases, hepatic enzymes that indicate cell damage.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bethany Bixler Quinn, PA 535 Maxham Rd, Suite A, Austell, GA 30168-5541 Ph: (770) 948-6041 | Bethany Bixler Quinn, PA 3820 Medical Park Dr, Austell, GA 30106-1110 Ph: (770) 948-6041 |
News Archive
Cancer scientists led by Dr. John Dick at the Princess Margaret Cancer Centre have found a way to follow single tumour cells and observe their growth over time. By using special immune-deficient mice to propagate human colorectal cancer, they found that genetic mutations, regarded by many as the chief suspect driving cancer growth, are only one piece of the puzzle. The team discovered that biological factors and cell behaviour - not only genes - drive tumour growth, contributing to therapy failure and relapse.
United Auto Workers will sell its 55% stake in the reorganized Chrysler as soon as possible to fund a trust that will cover retirees' health care costs, UAW President Ron Gettelfinger said Monday, the AP/Houston Chronicle reports.
Secondhand tobacco smoke and smoke from cooking oil and wood smoke affected cardiovascular function of men and women who were exposed to small doses of the smoke for as little as 10 minutes, according to a study from the University of Kentucky.
The U.S. Food and Drug Administration today approved Xalkori (crizotinib) to treat people with advanced (metastatic) non-small cell lung cancer (NSCLC) whose tumors have an ROS-1 gene alteration. Xalkori is the first and only FDA approved treatment for patients with ROS-1 positive NSCLC.
Results from a multinational phase II study presented today at the International Liver CongressTM 2010 have shown that treatment with the caspase inhibitor GS-9450 can reduce markers of liver damage in patients with non-alcoholic steatohepatitis (NASH - the most serious form of non-alcoholic liver disease) as demonstrated by reduced levels of alanine and aspartate aminotransferases, hepatic enzymes that indicate cell damage.
› Verified 6 days ago
Mrs. Lauren S Snyder, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1700 Hospital South Dr Ste 300, Austell, GA 30106 Phone: 770-944-2830 Fax: 678-581-7170 | |
Ms. Melissa Anne Martel, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 3950 Austell Rd, Austell, GA 30106 Phone: 770-732-4000 | |
Mr. Jeffrey N Hairston, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2041 Mesa Valley Way, Suite 100, Austell, GA 30106 Phone: 770-944-1100 Fax: 770-941-7227 | |
Brandon Lee Eshleman, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 3672 Marathon Cir, Suite 200, Austell, GA 30106 Phone: 770-944-3303 Fax: 770-944-0285 | |
Lauren Cannon, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3950 Austell Rd, Austell, GA 30106 Phone: 706-863-9595 Fax: 706-868-8375 | |
Douglas A. Hernandez, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 2041 Mesa Valley Way Ste 100, Austell, GA 30106 Phone: 770-944-1100 |